Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2022-10-20

Clinical Trial Update: Diffuse Intrinsic Pontine Glioma (DIPG) Reirradiation (ReRT) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update on reirradiation for diffuse intrinsic pontine glioma (DIPG) is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Brain Cancer | Phase 1, Phase 2 | Status: COMPLETED